Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
Titel:
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
Auteur:
Pujade-Lauraine, Eric Ledermann, Jonathan A Selle, Frédéric Gebski, Val Penson, Richard T Oza, Amit M Korach, Jacob Huzarski, Tomasz Poveda, Andrés Pignata, Sandro Friedlander, Michael Colombo, Nicoletta Harter, Philipp Fujiwara, Keiichi Ray-Coquard, Isabelle Banerjee, Susana Liu, Joyce Lowe, Elizabeth S Bloomfield, Ralph Pautier, Patricia